| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8745210 | Egyptian Journal of Chest Diseases and Tuberculosis | 2017 | 5 Pages |
Abstract
Serum-Retinol-Binding Protein-4 can be used as a predictive biomarker for mortality in AECOPD. We recommend that the serum RBP4 should be taken in consideration as a part of the assessment of mortality of AECOPD patients admitted in ICU.
Related Topics
Health Sciences
Medicine and Dentistry
Infectious Diseases
Authors
Samiha S. Ashmawi, Nermine M. Riad, Mohammed A. Saeed,